Vulvar cancer epidemiology and demographics: Difference between revisions
No edit summary |
|||
Line 13: | Line 13: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | ||
|- | |- | ||
|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Age''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''<20''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''20-34''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''35-44''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''45-54''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''55-64''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''65-74''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''75-84''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''>85''' | |style="padding: 0 5px; font-size: 100%; background: #DCDCDC#4479BA; color: F5F5F5; width: 10%" align=center |'''Age''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''<20''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''20-34''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''35-44''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''45-54''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''55-64''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''65-74''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''75-84''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''>85''' | ||
|- | |- | ||
| style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Incidence''' | | style="padding: 0 5px; font-size: 100%; background: #4479BA; color: #FFFFFF; width: 10%" align=center |'''Incidence''' |
Revision as of 19:06, 7 October 2015
Vulvar cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vulvar cancer epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics |
Risk calculators and risk factors for Vulvar cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2]
Overview
In 2012, the incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The incidence of vulvar cancer increases with age; the median age at diagnosis is 68 years and it is more prevalent in the caucasian.[1]
Epidemiology and Demographics
Incidence
The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.[1]
Age
Age | <20 | 20-34 | 35-44 | 45-54 | 55-64 | 65-74 | 75-84 | >85 |
Incidence | 0.2% | 2% | 6.1% | 15.3% | 19.8% | 19.8% | 22.1% | 14.9% |
Race
- Vulvar cancer is more prevalent in the caucasian.[1]
Race | All Races | White | Black | Asian/Pacific Islander | American Indian/Alaska Native | Hispanic | Non-Hispanic |
Incidence | 2.4 per 100,000 | 2.6 per 100,000 | 1.8 per 100,000 | 0.9 per 100,000 | 2.0 per 100,000 | 1.7 per 100,000 | 2.5 per 100,000 |
References
- ↑ 1.0 1.1 1.2 1.3 SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015